Feb 20 2019
On February 15, Heart.org reviewed the outcomes of a study published in the New England Journal documenting the clinical efficacy of andexanet alfa (Andexxa). The study is the first to illustrate clinical outcomes, cessation of bleeding, compared to previous data that used laboratory outcomes as evidence for reversal. Click or tap here to see the article in Medscape Oncology.
Comments (0)Anticoagulant Therapy
No comments here.